Registration for a live webinar on 'Chronic inflammation, immune cell trafficking and anti-trafficking agents' is now open.See webinar details
Dr. Stephen R. Hammes University of Rochester Medical Center, USA1 Talk
Dr. Hammes graduated from Cornell University in 1985. He completed his M.D. as well as his Ph.D. in Microbiology and Immunology from Duke University in 1993. Dr. Hammes then moved to the University of California in San Francisco (UCSF), where he completed an internship and residency in General Medicine, followed... read moreby a fellowship in Endocrinology. In 1999, Dr. Hammes joined the faculty at the University of Texas Southwestern Medical Center in Dallas, where he was a W.W. Caruth Scholar in Biomedical Research and Co-Director of the Endocrinology Fellowship program. Dr. Hammes moved to the University of Rochester in 2009 to become the Louis S. Wolk Distinguished Professor of Medicine and the Chief of the Division of Endocrinology, Diabetes, and Metabolism.
In addition to serving at the Endocrinology Fellowship Program Director for several years at Rochester, Dr. Hammes is currently the Executive Vice Chair in the Department of Medicine at the University of Rochester. Dr. Hammes has served as Editor-in-Chief of the scientific journals “Molecular Endocrinology” and “Endocrinology,” and is currently Deputy Editor of the “Journal of the Endocrine Society.” He is a member of the American Society for Clinical Investigation. Dr. Hammes’ research interests include steroidogenesis and steroid signaling, with a focus on extranuclear, or nongenomic, steroid effects. He studies these processes in the setting of female reproduction, where his lab has demonstrated the importance of androgen signaling in the ovary. In addition, the Hammes lab studies steroid hormone signaling in hormone-sensitive cancers such as prostate cancer and lymphangioleiomyomatosis (LAM).